Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$438M |
| 3 |
lululemon athletica
LULU
|
+$407M |
| 4 |
Qualcomm
QCOM
|
+$393M |
| 5 |
NVIDIA
NVDA
|
+$376M |
Top Sells
| 1 |
Under Armour
UAA
|
+$1.04B |
| 2 |
Abbott
ABT
|
+$758M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$516M |
| 5 |
MON
Monsanto Co
MON
|
+$453M |
Sector Composition
| 1 | Consumer Discretionary | 19.2% |
| 2 | Healthcare | 16.74% |
| 3 | Technology | 15.05% |
| 4 | Communication Services | 12.7% |
| 5 | Financials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICD
451
DELISTED
Independence Contract Drilling, Inc.
ICD
| $11.7M | 0.01% |
108,071
-65
| -0.1% | -$7.06K |
|
|
ATHN
452
DELISTED
Athenahealth, Inc.
ATHN
| $11.6M | 0.01% |
83,826
+33,016
| +65% | +$4.56M |
|
453
Assembly Biosciences
ASMB
$177M
| $11.3M | 0.01% |
169,795
-164
| -0.1% | -$10.9K |
|
454
Liberty Global Class C
LBTYK
$4.03B
| $11.2M | 0.01% |
390,774
-569,333
| -59% | -$16.3M |
|
455
Brookfield Infrastructure Partners
BIP
$14.3B
| $10.3M | 0.01% |
570,997
-75,134
| -12% | -$1.35M |
|
|
KA
456
DELISTED
Kineta, Inc. Common Stock
KA
| $10.1M | 0.01% |
5,965
-7
| -0.1% | -$11.9K |
|
|
GNMX
457
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $9.74M | 0.01% |
1,755,035
-6,009
| -0.3% | -$33.3K |
|
|
AGTC
458
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $9.66M | 0.01% |
683,451
-989
| -0.1% | -$14K |
|
|
SLCA
459
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $9.57M | 0.01% |
+277,618
| New | +$9.57M |
|
460
Kosmos Energy
KOS
$780M
| $9.51M | 0.01% |
1,744,243
-136,834
| -7% | -$746K |
|
461
Marcus & Millichap
MMI
$1.27B
| $9.23M | 0.01% |
363,306
-25,592
| -7% | -$650K |
|
|
NS
462
DELISTED
NuStar Energy L.P.
NS
| $9.2M | 0.01% |
184,639
+72,184
| +64% | +$3.59M |
|
|
AEUA
463
DELISTED
Anadarko Petroleum Corporation
AEUA
| $8.87M | 0.01% |
242,018
+31,397
| +15% | +$1.15M |
|
464
Oneok
OKE
$45.7B
| $8.77M | 0.01% |
184,771
+18,791
| +11% | +$892K |
|
|
MPG
465
DELISTED
Metaldyne Performance Group Inc.
MPG
| $8.64M | 0.01% |
628,006
-241,678
| -28% | -$3.32M |
|
|
ZEN
466
DELISTED
ZENDESK INC
ZEN
| $8.14M | 0.01% |
+308,711
| New | +$8.14M |
|
467
Chefs' Warehouse
CHEF
$2.64B
| $8.08M | 0.01% |
+505,166
| New | +$8.08M |
|
468
Corvus Pharmaceuticals
CRVS
$457M
| $8.07M | 0.01% |
570,481
+106,349
| +23% | +$1.5M |
|
469
HubSpot
HUBS
$26.5B
| $7.87M | 0.01% |
+181,208
| New | +$7.87M |
|
|
FENX
470
DELISTED
Fenix Parts, Inc.
FENX
| $7.77M | 0.01% |
1,976,971
+13,784
| +0.7% | +$54.2K |
|
471
Planet Fitness
PLNT
$8.62B
| $7.55M | 0.01% |
+400,000
| New | +$7.55M |
|
|
RRMS
472
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $7.5M | 0.01% |
284,069
+57,379
| +25% | +$1.51M |
|
|
CIE
473
DELISTED
Cobalt International Energy, Inc
CIE
| $7.31M | 0.01% |
363,545
-22,294
| -6% | -$448K |
|
|
GWPH
474
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $7.13M | 0.01% |
+77,871
| New | +$7.13M |
|
475
Agios Pharmaceuticals
AGIO
$2.12B
| $7.12M | 0.01% |
169,974
-312,123
| -65% | -$13.1M |
|